ImmunoPrecise Antibodies ...

NASDAQ: IPA · Real-Time Price · USD
0.44
-0.02 (-3.83%)
At close: May 09, 2025, 3:01 PM

ImmunoPrecise Antibodies Revenue

ImmunoPrecise Antibodies reported an annual revenue of $24.52M, reflecting a 18.65% growth. For the quarter ending January 31, 2025, ImmunoPrecise Antibodies generated $6.15M in revenue.
Revenue (ttm)
$24.52M
Revenue Growth
18.65%
Price / Sales Ratio
1.84
Revenue / Employee
$340.53K
Employees
72
Market Cap
20M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.